BOSTON, MA and PARIS, FRANCE--(Marketwire - April 27, 2010) - KIKA™ Clinical Solutions, the leader in advanced EDC solutions for Clinical Asset Management™, announced a partnership with a Danish CRO BioStata ApS. KIKA provides the groundbreaking Veracity™ EDC platform.
BioStata is an international company that specializes in statistics and worldwide EAC and DMC/DSMB services. It offers a complete SOP system and a large network of clinicians and statisticians to ensure a high updated level of service.
Bjarne Bodin, CEO of BioStata, said, "We choose KIKA because wanted to set up a fast and easy way to enter events and perform online event adjudication. We also wanted a secure means for exchanging confidential information with the DMCs. We have the perfect complementary technology to facilitate these services with Veracity™."
KIKA CEO Linda Beneze said, "The use of DMC/DSMB and EAC is increasing. Sponsors want the security of experienced people and bulletproof validated systems. KIKA and BioStata complement each other's offerings to provide sponsors the combination of a top EDC platform and excellent CRO services."
About KIKA Clinical Solutions
KIKA helps the world's most innovative biopharmaceutical and medical device organizations use advanced EDC solutions to bring much-needed medical solutions to market faster. KIKA's Veracity™ is the leading-edge Web-based clinical trial software platform that delivers Clinical Asset Management™ for any size clinical trial. Veracity is customized to meet study needs precisely. It provides unmatched flexibility and customization with advanced EDC including images and online adjudication. Veracity is backed by the industry's most reliable IT infrastructure and a world class Professional Services organization. For more information, visit www.kikaclinicalsolutions.com.
KIKA, Veracity and Clinical Asset Management are trademarks of the KIKA group of companies.
Follow KIKA on Facebook and on Twitter.